secwatch.observer — SEC 8-K summary
======================================

Issuer:     UTAH MEDICAL PRODUCTS INC (UTMD)
CIK:        0000706698
Form:       8-K
Filed at:   2025-11-04T23:59:59+00:00
Accession:  0001096906-25-001733
Event type: other_material
Sentiment:  positive
Materiality: 0.40
Item codes: 5.02, 8.01, 9.01, 99.1
LLM model:  deepseek-v4-flash:cloud@v2

Utah Medical Products appoints director, increases quarterly dividend to $0.31/share
--------------------------------------------------------------------------------

- Appointed Kevin Timken to board, increasing size to 6; he joins Audit and Compensation committees.
- Timken received 10,000 stock options at $58.10, vesting over 4 years; quarterly fee $7,650 pro-rated.
- Quarterly cash dividend raised to $0.31 per share, payable Jan 5, 2026 to holders of record Dec 16, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/706698/000109690625001733/0001096906-25-001733-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/706698/000109690625001733/utmd-20251104_8k.htm
  HTML page:      https://secwatch.observer/filing/0001096906-25-001733

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer